N-(4-((4-amino-2-butyl-1H-imidazo[4,5-c]quinolin-1-yl)methyl)benzyl)-3,3'-dihydroxybiphenyl-4-carboxamide

ID: ALA4871318

Chembl Id: CHEMBL4871318

PubChem CID: 163196239

Max Phase: Preclinical

Molecular Formula: C35H33N5O3

Molecular Weight: 571.68

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCc1nc2c(N)nc3ccccc3c2n1Cc1ccc(CNC(=O)c2ccc(-c3cccc(O)c3)cc2O)cc1

Standard InChI:  InChI=1S/C35H33N5O3/c1-2-3-11-31-39-32-33(27-9-4-5-10-29(27)38-34(32)36)40(31)21-23-14-12-22(13-15-23)20-37-35(43)28-17-16-25(19-30(28)42)24-7-6-8-26(41)18-24/h4-10,12-19,41-42H,2-3,11,20-21H2,1H3,(H2,36,38)(H,37,43)

Standard InChI Key:  PPOLLAZGKOEUCM-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4871318

    ---

Associated Targets(non-human)

Tlr7 TLR7 and TLR8 (70 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAW264.7 (28094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 571.68Molecular Weight (Monoisotopic): 571.2583AlogP: 6.57#Rotatable Bonds: 9
Polar Surface Area: 126.29Molecular Species: NEUTRALHBA: 7HBD: 4
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 7.99CX Basic pKa: 4.87CX LogP: 7.33CX LogD: 7.23
Aromatic Rings: 6Heavy Atoms: 43QED Weighted: 0.16Np Likeness Score: -0.72

References

1. Kimani FW, Manna S, Moser B, Shen J, Nihesh N, Esser-Kahn AP..  (2021)  Improving the Adjuvanticity of Small Molecule Immune Potentiators Using Covalently Linked NF-κB Modulators.,  12  (9.0): [PMID:34527180] [10.1021/acsmedchemlett.1c00267]

Source